One expert explains what patients with prostate cancer interested in clinical trial participation need to know. For patients with prostate cancer who are interested in participating in clinical trials ...

Agency staff expressed uncertainty over whether PFS benefit was "clinically meaningful" ...

It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...

Prostate massages are a fairly unexplored thing for most men. Society isn’t exactly a judgment-free space, and the stigma associated with using prostate massagers can make it feel wrong to explore the ...

New research suggests that men who take multivitamins after being diagnosed with prostate cancer may have a lower risk of cancer recurrence. In the overall study group, current multivitamin users ...

An FDA advisory panel has voted 7-1, with one abstention, to recommend expanding the use of AstraZeneca’s capivasertib (Truqap) for PTEN-deficient metastatic hormone-sensitive prostate cancer. The ...

In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy. Combining gene therapy ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

Please provide your email address to receive an email when new articles are posted on . Former marijuana users had significantly fewer reports of prostate cancer compared with nonusers Multivariate ...

For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track ...